Restless legs syndrome: treatment with dopaminergic agents.
about
Role of central dopamine in pain and analgesiaSleep and aging: 2. Management of sleep disorders in older peopleDiagnosis and treatment of sleep disorders: a brief review for clinicians.Impairment of sensory-motor integration in patients affected by RLS.Novel pharmacotherapy for fibromyalgia.Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes.Medication tolerance and augmentation in restless legs syndrome: the need for drug class rotation.Excessive daytime sleepiness in sleep disordersThe weight of evidence for ropinirole in restless legs syndrome.Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system.Restless legs syndrome: pathophysiology, diagnosis and treatment.Pramipexole: new use for an old drug - the potential use of pramipexole in the treatment of restless legs syndromePramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers.Demographic and clinical characteristics of patients with restless legs syndrome in spine clinic.ADMET considerations for restless leg syndrome drug treatments.ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome.Restless legs syndrome: symptoms, management and new developments.Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy.Effects of pergolide on severe sleep bruxism in a patient experiencing oral implant failure.A preliminary look at the percentage of patients with Restless Legs Syndrome who also have Parkinson Disease, Essential Tremor or Tourette Syndrome in a single practice.Effects of the 5HT2C antagonist SB242084 on the pramipexole-induced potentiation of water contrafreeloading, a putative animal model of compulsive behavior.Aerobic exercise improves signs of restless leg syndrome in end stage renal disease patients suffering chronic hemodialysis.Peripheral Dopamine in Restless Legs Syndrome.Polysomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome
P2860
Q22241489-06B30E52-792B-40B7-9422-DD7210074F9DQ24674548-D476FE76-9D3D-4680-BE82-D3A47DE36EA3Q30473423-4D7A7D25-7C82-4159-ACE8-4F646277A4A6Q34126298-A3275485-8778-418E-8335-3547EDEC6A07Q34628135-32DA88D8-57B3-4594-AC81-605D66C42F4BQ35876352-AEEAA168-B509-45BA-88F7-92457E8C4A78Q35901664-969BA68A-9503-4CD1-B830-179E64988ACFQ36424408-5EE9AD68-7DB2-475E-AA29-3ADDE000B87CQ36575984-CD4A79DE-1A20-4AEB-B558-C5FCD666ECDEQ36834242-211C6624-16A3-45E5-8BBF-4504C349A9F8Q37165507-D5EF546A-52B2-4B34-A664-2DA818F15E08Q37166103-4ADE06A1-7859-47F7-AF10-CB6319C71775Q37345319-53C207E2-6366-4866-A018-EF9121804814Q37644659-AD3545C9-5734-4820-B5BC-98E1A42ACB60Q38027180-99240BDB-FC85-4071-AA0E-F7F7835C1066Q38242390-B2136BFB-218A-43EC-BDC9-F5E7588BB03EQ46636964-E0B81944-9D1F-4F03-9B8B-F3FE838AA520Q48368641-BFF462E9-8BC6-41BE-B2AC-1E7BAC53583AQ48471465-5C995CD3-2F9C-4447-91DD-A403C30F6854Q48610300-115A25DF-5BE1-48CE-BA8C-80D68C50AC72Q50770358-E4F96676-8FEF-4B01-9C16-E7129D1D2BA5Q54487276-FC2B7FAE-7070-4461-8D5C-7AEB8252E2CDQ54969192-66012029-E474-4BA8-949D-070EA08137A7Q56998697-EBCB9BA5-9DBD-4C8A-AC2E-42C8E3674709
P2860
Restless legs syndrome: treatment with dopaminergic agents.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Restless legs syndrome: treatment with dopaminergic agents.
@ast
Restless legs syndrome: treatment with dopaminergic agents.
@en
Restless legs syndrome: treatment with dopaminergic agents.
@nl
type
label
Restless legs syndrome: treatment with dopaminergic agents.
@ast
Restless legs syndrome: treatment with dopaminergic agents.
@en
Restless legs syndrome: treatment with dopaminergic agents.
@nl
prefLabel
Restless legs syndrome: treatment with dopaminergic agents.
@ast
Restless legs syndrome: treatment with dopaminergic agents.
@en
Restless legs syndrome: treatment with dopaminergic agents.
@nl
P1433
P1476
Restless legs syndrome: treatment with dopaminergic agents.
@en
P2093
Cynthia L Comella
P304
P356
10.1212/WNL.58.SUPPL_1.S87
P407
P433
P577
2002-02-01T00:00:00Z